ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
Mechanisms of atrial fibrosis including the role of serotonin in the development of this lesion in patients with atrial fibrillation are presented. New approaches to the treatment of atrial fibrillation aimed at atrial fibrosis reduction are discussed.
Saved in:
Main Authors: | O. M. Drapkina, A. V. Emelyanov |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/106 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01) -
Pathogenic Mechanisms of Atrial Fibrillation in Obesity
by: O. M. Drapkina, et al.
Published: (2016-11-01) -
Myocardial fibrosis and atrial fibrillation
by: S. V. Grigoryan, et al.
Published: (2018-09-01) -
Comparative evaluation of markers of inflammation and fibrosis in patients with various clinical forms of atrial fibrillation
by: S. V. Grigoryan, et al.
Published: (2018-12-01) -
Angiogenesis in Atrial Fibrillation: A Literature Review
by: Jie Lin, et al.
Published: (2025-06-01)